Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...

Delgocitinib tripled week-16 treatment success versus placebo (RR 3.17), yielding an absolute 16.9% benefit and NNT of 6. Early separation by week 4 supports adherence, with sustained superiority at ...

Senate Democrats introduced a bill to cap out-of-pocket costs at $5000 for traditional Medicare beneficiaries and expand low-income assistance. Traditional Medicare does not currently have a limit on ...

COA’s AI Playbook provides a structured, practice-oriented framework to prioritize AI use cases, align stakeholders, and ...

Learn how aggressive neuroendocrine carcinoma disrupts daily life—and why rapid treatment, strong caregiver support, and navigation resources matter. In this episode, ‘Current Treatments and Biomarker ...

Wastewater signals suggest increasing SARS-CoV-2 circulation despite low national baselines, reinforcing surveillance as an early indicator rather than a definitive predictor of near-term clinical ...

CDC ended the federal response June 24, 2026, after risk diminished, releasing >100 deployed staff from the peak incident ...

AML management now hinges on molecularly defined subtypes, supported by numerous targeted approvals; expanding trial access ...

Recent data from the National Cancer Institute (NCI) suggest that the number of people in the US diagnosed with diffuse large ...

From overtreating good-risk patients to searching for a cure, Adam Kittai, MD, Perlmutter Cancer Center, outlines where CLL ...

National health spending is forecast to approach $9 trillion by 2034, increasing faster than GDP and consuming 20.6% of the ...

Tebipenem pivoxil becomes the only FDA-approved oral carbapenem for complicated UTIs/pyelonephritis in adults lacking viable ...